Growth Metrics

Baxter International (BAX) Common Equity (2016 - 2025)

Historic Common Equity for Baxter International (BAX) over the last 17 years, with Q3 2025 value amounting to $7.2 billion.

  • Baxter International's Common Equity fell 882.65% to $7.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 billion, marking a year-over-year decrease of 882.65%. This contributed to the annual value of $7.0 billion for FY2024, which is 1705.24% down from last year.
  • According to the latest figures from Q3 2025, Baxter International's Common Equity is $7.2 billion, which was down 882.65% from $7.3 billion recorded in Q2 2025.
  • Over the past 5 years, Baxter International's Common Equity peaked at $9.1 billion during Q4 2021, and registered a low of $5.6 billion during Q3 2022.
  • For the 5-year period, Baxter International's Common Equity averaged around $7.6 billion, with its median value being $7.9 billion (2024).
  • Examining YoY changes over the last 5 years, Baxter International's Common Equity showed a top increase of 4637.03% in 2023 and a maximum decrease of 3675.17% in 2023.
  • Quarter analysis of 5 years shows Baxter International's Common Equity stood at $9.1 billion in 2021, then crashed by 35.37% to $5.9 billion in 2022, then soared by 43.65% to $8.5 billion in 2023, then decreased by 17.05% to $7.0 billion in 2024, then grew by 3.09% to $7.2 billion in 2025.
  • Its Common Equity was $7.2 billion in Q3 2025, compared to $7.3 billion in Q2 2025 and $7.1 billion in Q1 2025.